ICM
SAL

Invenomic Capital Management’s Salisbury Bancorp, Inc. SAL Stock Holding History

Invenomic Capital Management’s Portfolio SAL Stock Details SAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,110
Closed -$79K – 150
2021
Q2 		$79K Buy
+3,110
New +$71.5K 0.02% 119

Other funds holding SAL

FCM
FJ Capital Management Mclean, Virginia $888M AUM 18.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFC
Banc Funds Company Chicago, Illinois $537M AUM 17.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Invenomic Capital Management's SAL Position: Q3 2021 in Review

Invenomic Capital Management sold out of Salisbury Bancorp, Inc. (SAL) in Q3 2021, closing a stake of 3,110 shares — an estimated $79K sold.

Invenomic Capital Management first reported a position in SAL in Q2 2021 and held it in 1 quarter. The position peaked at $79K in Q2 2021. 45 funds tracked by Wall St. Rank hold SAL as of Q3 2021.

  • Invenomic Capital Management reported no remaining Salisbury Bancorp, Inc. position as of Q3 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 3,110 Salisbury Bancorp, Inc. shares in Q3 2021, an estimated $79K.
  • Invenomic Capital Management first reported a position in Salisbury Bancorp, Inc. in Q2 2021 and held it in 1 quarter.
  • Invenomic Capital Management's Salisbury Bancorp, Inc. position peaked at $79K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Salisbury Bancorp, Inc. as of Q3 2021.

Based on Invenomic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.